Related Experiment Video
Updated: Aug 3, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Clinical Characterization and Outcomes of Patients with Hypercreatinemia Affected by COVID-19
Ahmed M E Elkhalifa1,2, Naveed Nazir Shah3, Zaid Khan3
1Department of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh 11673, Saudi Arabia.
Insights
Patients with hypercreatinemia (elevated creatinine) hospitalized with COVID-19 faced higher risks of severe illness, intensive care unit (ICU) admission, and death. Managing kidney function may improve COVID-19 patient outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Hypercreatinemia, an indicator of kidney dysfunction, is increasingly recognized as a potential comorbidity in COVID-19 patients.
- Understanding the impact of pre-existing kidney issues on COVID-19 severity and outcomes is crucial for clinical management.
Purpose of the Study:
- To investigate the clinical presentation and outcomes of COVID-19 patients with hypercreatinemia upon hospital admission.
- To identify risk factors associated with mortality in COVID-19 patients with elevated creatinine levels.
Main Methods:
- A retrospective observational study involving 1668 COVID-19 patients hospitalized between March 2020 and April 2021.
- Analysis of clinical data, including intensive care unit (ICU) admission, disease severity, mechanical ventilation, and mortality rates.
- Multivariable analysis to determine independent risk factors for in-hospital mortality.
Main Results:
- Out of 1668 patients, 339 presented with hypercreatinemia.
- Hypercreatinemic patients showed significantly higher rates of ICU admission, severe COVID-19, mechanical ventilation, and all-cause mortality.
- Elevated creatinine, age, IL-1, D-Dimer, and Hs-CRP were independent predictors of in-hospital mortality, with creatinine strongly associated (HR 5.34).
Conclusions:
- Hypercreatinemia is a significant predictor of poor outcomes in hospitalized COVID-19 patients.
- Improving kidney function may be a therapeutic target to enhance outcomes for COVID-19 patients.
- Early identification and management of kidney dysfunction are vital in COVID-19 care.
Abstract:
The present study evaluated the clinical presentation and outcome of COVID-19 patients with underlying hypercreatinemia at the time of hospitalization. A retrospective observational study was conducted from the 23rd of March 2020 to the 15th of April 2021 in 1668 patients confirmed positive for COVID-19 in the Chest Disease Hospital in Srinagar, India. The results of the present study revealed that out of 1668 patients, 339 with hypercreatinemia had significantly higher rates of admission to the intensive care unit (ICU), severe manifestations of the disease, need for mechanical ventilation, and all-cause mortality. Multivariable analysis revealed that age, elevated creatinine concentrations, IL-1, D-Dimer, and Hs-Crp were independent risk factors for in-hospital mortality. After adjusted analysis, the association of creatinine levels remained strongly predictive of all-cause, in-hospital mortality (HR-5.34; CI-4.89-8.17; p ≤ 0.001). The amelioration of kidney function may be an effective method for achieving creatinemic targets and, henceforth, might be beneficial for improving outcomes in patients with COVID-19.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention

